Here's Why Henry Schein (HSIC) is a Strong Growth Stock

According to Zacks Investment Research, Henry Schein (HSIC), a global distributor of healthcare products and services, is a stock to watch for growth investors. While HSIC holds a Zacks Rank #3 (Hold), it boasts a VGM Score of A and a Growth Style Score of B, with a projected 2.5% year-over-year earnings growth for the current fiscal year; furthermore, the consensus earnings estimate for fiscal year 2025 has increased by $0.02 to $4.86 per share following upward revisions by four analysts in the last 60 days.

Analysis

Henry Schein (HSIC), a global healthcare products and services distributor operating in 33 countries, presents a nuanced investment profile according to Zacks Investment Research. While assigned a Zacks #3 (Hold) rank, which typically suggests a neutral short-term outlook based on earnings estimate revisions, HSIC scores favorably with an 'A' for its overall VGM (Value, Growth, Momentum) Score and a 'B' for its Growth Style Score. This positive assessment is supported by a projected 2.5% year-over-year earnings growth for the current fiscal year and an average earnings surprise of 2.4%. Furthermore, analyst sentiment for fiscal 2025 is improving, evidenced by four upward earnings estimate revisions in the last 60 days, which has lifted the Zacks Consensus Estimate by $0.02 to $4.86 per share. This combination of strong style scores and positive estimate trends for the upcoming fiscal year positions HSIC as a noteworthy stock for investors focused on growth, despite its current 'Hold' status which warrants consideration.

Key Decisions for Investors

• Investors should note the contrast between HSIC's neutral Zacks #3 (Hold) rank and its strong 'A' VGM and 'B' Growth Style Scores, which, alongside positive fiscal year 2025 earnings estimate revisions, may signal underlying strength appealing to growth-focused portfolios.
• Consider HSIC's projected 2.5% current fiscal year earnings growth and its consistent 2.4% average earnings surprise as potentially positive indicators, but remain mindful that the 'Hold' rank suggests limited near-term catalysts according to the Zacks model.
• Monitor future earnings reports and analyst estimate revisions closely, as sustained positive momentum in these areas could lead to an upgrade in the Zacks Rank and further validate the growth thesis suggested by its style scores.